Evidence map›Paper›PMID 35821807›Full record

ArticleFrontiers in aging2022

Somatic Mutations Detected in Parkinson Disease Could Affect Genes With a Role in Synaptic and Neuronal Processes.

Irene Lobon, Manuel Solís-Moruno, David Juan, Ashraf Muhaisen, Federico Abascal, Paula Esteller-Cucala, Raquel García-Pérez, Maria Josep Martí, Eduardo Tolosa, Jesús Ávila and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in aging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Compound Heterozygous Structural Variants in Cases with Unsolved PRKN-Associated Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  4. Article
  5. Article
  6. Parkinson's Disease is Predominantly a Genetic Disease.Journal of Parkinson's disease · 2024
    Review
  7. Article
  8. Elevated E200K Somatic Mutation of the Prion Protein Gene (International journal of molecular sciences · 2023
    Article
  9. Mitigating age-related somatic mutation burden.Trends in molecular medicine · 2023
    Review
  10. Somatic genetic variation in healthy tissue and non-cancer diseases.European journal of human genetics : EJHG · 2023
    Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Irene LobonInstitute of Evolutionary Biology (UPF-CSIC), Barcelona, Spain.
Manuel Solís-MorunoGenomics Core Facility, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.
David JuanInstitute of Evolutionary Biology (UPF-CSIC), Barcelona, Spain.
Ashraf MuhaisenDepartment of Cell Biology, Physiology and Immunology and Institute of Neurosciences, Universitat de Barcelona (UB), Barcelona, Spain.
Federico AbascalCancer, Ageing, and Somatic Mutation (CASM), Wellcome Sanger Institute, Cambridge, United Kingdom.
Paula Esteller-CucalaInstitute of Evolutionary Biology (UPF-CSIC), Barcelona, Spain.
Raquel García-PérezInstitute of Evolutionary Biology (UPF-CSIC), Barcelona, Spain.
Maria Josep MartíCentre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
Eduardo TolosaCentre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
Jesús ÁvilaCentre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
Raheleh RahbariCancer, Ageing, and Somatic Mutation (CASM), Wellcome Sanger Institute, Cambridge, United Kingdom.
Tomas Marques-BonetInstitute of Evolutionary Biology (UPF-CSIC), Barcelona, Spain.
Ferran CasalsGenomics Core Facility, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.
Eduardo SorianoDepartment of Cell Biology, Physiology and Immunology and Institute of Neurosciences, Universitat de Barcelona (UB), Barcelona, Spain.
Institut de Biologia Evolutiva · ESBiomedical Research Networking Center on Neurodegenerative Diseases · ESUniversitat de Barcelona · ESWellcome Sanger Institute · GBCentre for Genomic Regulation · ESCentro de Biología Molecular Severo Ochoa · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of somatic mutations in complex diseases, including neurodevelopmental and neurodegenerative disorders, is becoming increasingly clear. However, to date, no study has shown their relation to Parkinson disease's phenotype. To explore the relevance of embryonic somatic mutations in sporadic Parkinson disease, we performed whole-exome sequencing in blood and four brain regions of ten patients. We identified 59 candidate somatic single nucleotide variants (sSNVs) through sensitive calling and a careful filtering strategy (COSMOS). We validated 27 of them with amplicon-based ultra-deep sequencing, with a 70% validation rate for the highest-confidence variants. The identified sSNVs are in genes with synaptic functions that are co-expressed with genes previously associated with Parkinson disease. Most of the sSNVs were only called in blood but were also found in the brain tissues with ultra-deep amplicon sequencing, demonstrating the strength of multi-tissue sampling designs.

Indexed as

brain mosaicismneurodegenarationParkinson diseasesomatic genome alterationsomatic mutations

Identifiers

PMID35821807
PMCPMC9261316
OpenAlexW4224981894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.